Long-Term Exposure to Imatinib Mesylate Downregulates Hippo Pathway and Activates YAP in a Model of Chronic Myelogenous Leukemia
Anna Chorzalska, Javier Flores Kim, Karim Roder, Alexander Tepper, Nagib Ahsan, R. Shyama Prasad Rao, Adam J. Olszewski, Xiaoqing Yu, Dmitry Terentyev, John Morgan, DIana O. Treaba, Ting C. Zhao, Olin Liang, Philip A. Gruppuso, Patrycja M. Dubielecka
Research output: Contribution to journal › Article › peer-review
19Scopus
citations
Fingerprint
Dive into the research topics of 'Long-Term Exposure to Imatinib Mesylate Downregulates Hippo Pathway and Activates YAP in a Model of Chronic Myelogenous Leukemia'. Together they form a unique fingerprint.